Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Completed 3

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 4Neoplasms 3Lung Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Thyroid Neoplasms 1Thyroid Diseases 1Substance-Related Disorders 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Papillomavirus Infections 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Leukemia 1HIV Infections 1Death 1Coitus 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Focus Groups × Clear all
NCT07382557 2026-02-03

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

M.D. Anderson Cancer Center

Phase NA Recruiting
360 enrolled
Thoracic

Lung Neoplasms

NCT05833334 2026-01-30

HHS

Dartmouth-Hitchcock Medical Center

Phase NA Recruiting
172 enrolled
Thoracic

Lung Neoplasms, Smoking

NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡